Boothbay Fund Management LLC Sells 224 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Boothbay Fund Management LLC decreased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 26.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 615 shares of the biotechnology company’s stock after selling 224 shares during the period. Boothbay Fund Management LLC’s holdings in Axon Enterprise were worth $366,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in AXON. Asset Dedication LLC increased its position in shares of Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares during the period. Bleakley Financial Group LLC increased its holdings in Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after purchasing an additional 20 shares during the period. Venturi Wealth Management LLC increased its holdings in Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after purchasing an additional 21 shares during the period. Burns Matteson Capital Management LLC lifted its holdings in Axon Enterprise by 3.4% in the 4th quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company’s stock worth $450,000 after buying an additional 25 shares during the period. Finally, Transcend Capital Advisors LLC grew its position in shares of Axon Enterprise by 3.6% in the 4th quarter. Transcend Capital Advisors LLC now owns 726 shares of the biotechnology company’s stock worth $431,000 after buying an additional 25 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Trading Up 1.3 %

Shares of NASDAQ AXON opened at $621.10 on Friday. The firm’s 50 day moving average price is $551.54 and its 200-day moving average price is $575.64. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market cap of $48.35 billion, a PE ratio of 160.49, a P/E/G ratio of 5.17 and a beta of 1.13.

Insider Buying and Selling at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the transaction, the chief executive officer now directly owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. This trade represents a 0.33 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 6.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on AXON. TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, April 23rd. Finally, The Goldman Sachs Group increased their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $626.45.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.